NHLBI Research Participant Recruitment Registry

Hematologic Disease and Disorders Clinical Trial

Official title:

NHLBI Research Participant Recruitment Registry

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04253769
• Other study ID #: 999920040
• Secondary ID: 20-H-N040
• Status: Not yet recruiting
• Start date: February 14, 2020
• Est. completion date: December 31, 2030

Study information

• Verified date: January 31, 2020
• Source: National Institutes of Health Clinical Center (CC)
• Contact: Sara E Hauffe
• Phone: (301) 385-2828
• Email: sara.hauffe[@]nih.gov
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Background:

The National Heart, Lung, and Blood Institute (NHLBI) conducts clinical trials that look at new ways to prevent, detect, or treat disease. It wants to create an NHLBI Recruitment Registry that lets people sign up to be contacted for NHLBI studies. It also wants to make sure that the data people share about themselves is safely stored. Researchers will be able to use this registry to prescreen people for clinical trials.

Objective:

To create and maintain an NHLBI research participant recruitment registry. This is an observational registry for collecting, storing, and providing access to data on people with a disease or condition of interest, or as a healthy volunteer to the NHLBI.

Eligibility:

People who contact the NIH to participate in an NHLBI IRB-approved study

Design:

Researchers will contact participants by telephone to obtain informed consent verbally.

Participants will give the following data:

• name

• date of birth

• phone number

• address

• email address

• diagnosis (if applicable)

• referring provider.

Participants will share how they heard of the study. They may give their medical records. They may be asked if they were enrolled in an NHLBI study in the past.

Participants will be asked if they would like to be contacted for other current or future studies. If they say no, they will not be contacted. But their data will stay in the database. They can also withdraw from the registry. If they do, their reason will be recorded in the database.

The registry will be created and maintained by the Office of the Clinical Director at NHLBI.

Description:

The objectives of this protocol are to develop and maintain an NHLBI research participant recruitment registry. An NHLBI Recruitment Registry will allow research teams to prescreen, safely store Protected Identifiable Information (PII) and contact potential research participants for NHLBI IRB approved protocols.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 99999
• Est. completion date: December 31, 2030
• Est. primary completion date: December 31, 2030
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

• INCLUSION CRITERIA:

Any potential participant who contacts the NIH for study participation

EXCLUSION CRITERIA:

None

Related Conditions & MeSH terms

• Cardiologic Disease and Disorders
• Disease
• Hematologic Disease and Disorders
• Hematologic Diseases
• Pulmonary Disease and Disorders

Locations

Country	Name	City	State
United States	National Heart, Lung and Blood Institute (NHLBI)	Bethesda	Maryland

Sponsors (1)

Lead Sponsor	Collaborator
National Heart, Lung, and Blood Institute (NHLBI)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The primary outcome is to develop and maintain an NHLBI research participant recruitment registry.	Registry will allow research teams to prescreen, safely store Protected Identifiable Information (PII) and contact potential research participants for NHLBI IRB approved protocols.	Ongoing